Dear Customer,
In light of the current global COVID-19 situation, the Watson-Marlow Fluid Technology
Group has implemented rigorous contingency plans to minimise the impact. As the
situation continues to develop, please be assured we remain committed to safeguarding
the health and well-being of our employees and customers.
We are adhering to local government guidelines and are reviewing the situation on a
constant basis. We have put in place clear procedures for our employees to protect their
health, including self-isolation where appropriate.
Many of our customers play a vital role in positively supporting the current situation,
from minimising the impact of the virus through the development of vaccines to food
production and water treatment. We realise that this work is of critical importance and
business continuity plans have been developed in all our business locations.
As a Company, we are adopting split-shift patterns to limit any potential of colleague
cross-contamination and working with our supply base to ensure continuity of supply.
We operate a global manufacturing strategy, with 10 manufacturing sites across Europe
and the US, in conjunction with a global footprint of warehousing to ensure a local
supply of products. We can reassure you that we have maintained a good stock profile
across our business and continue to work with our supply partners to maintain stock
levels.
We will continue to monitor the situation carefully and will take all necessary steps, at
the appropriate time and in line with national and international guidance, to help ensure
the safety of our employees, whilst minimising disruption to our customers.
Kind regards,
Andrew Mines
Managing Director Watson-Marlow Fluid Technology Group
